Your institution may have access to this item. Find your institution then sign in to continue.
Title
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.
Abstract
The article presents information on a study that evaluated the effect of pharmacogenetic CYP2D6 testing in clinical practice. The study aimed at determining whether genotype results affected choice of hormone therapy. The study concluded that CYP2D6 genotype testing leads to changes in therapy among poor metabolizers and even in the absence of definitive data that an alternative medicine improved outcomes.